During the past decade, David Geffen School of Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "David Geffen School of Medicine" are "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "David Geffen School of Medicine" in a lesser frequency.

Most popular intervention types in "David Geffen School of Medicine" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Treprostinil Diolamine" (1 trials) and "UT-15C (treprostinil diolamine)" (1 trials). Other intervention names were less common.

The vast majority of trials in "David Geffen School of Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "David Geffen School of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in David Geffen School of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in David Geffen School of Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".